| Financial Year |
March 31 2023 |
| Monetary Funds |
223,788,310.17 |
| Held-for-trading Financial Assets |
30,055,050.00 |
| Notes Receivable |
39,153,229.75 |
| Accounts Receivable |
153,730,466.38 |
| Advances to Suppliers |
69,908,295.02 |
| Other Receivables |
6,708,944.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
406,755,258.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,297,415.51 |
| Total Current Assets |
963,238,528.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,222,226.77 |
| Investment Properties |
-- |
| Fixed Assetes |
160,752,698.31 |
| Under-construction Projects |
6,196,641.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,887,597.97 |
| R&D expenses |
115,958,450.61 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
618,128.08 |
| Deferred Income Tax Assets |
7,434,844.38 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
385,144,245.59 |
| Total Assets |
1,348,382,773.66 |
| Short-Term Loans |
23,522,018.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,669,715.32 |
| Accounts Payable |
49,699,347.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,896,471.79 |
| Taxes Payable |
6,892,767.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,677,490.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,639,901.36 |
| Other Current Liabilities |
1,996,747.89 |
| Sub-Total of Current Liabilities |
187,500,134.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,294,765.10 |
| Deferred Income Tax Liabilities |
1,005,869.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,490,786.60 |
| Total Liabilities |
289,990,921.29 |
| Paid-In Capital(Or Share Stock) |
93,177,757.00 |
| Capital Surplus |
761,328,689.86 |
| Surplus Reserve |
18,594,356.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
185,200,690.32 |
| Minority Stockholder's Interest |
90,358.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,058,301,493.94 |
| Owner's Equity（Stockholder's Equity） |
1,058,391,852.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,348,382,773.66 |
